Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection  

作　　者：Rana Sager Isak Lindstedt Lars Edvinsson Marie-Louise Edvinsson 

机构地区：[1]Department of Emergency and Internal Medicine,Lund University Hospital of Skåne,Sweden [2]Department of Medicine,Institute of Clinical Sciences in Lund,Lund University,Sweden

出　　处：《Journal of Geriatric Cardiology》2020年第6期359-364,共6页老年心脏病学杂志（英文版）

基　　金：the Swedish Heart-Lung Foundation and the Swedish SUS Funds。

摘　　要：Heart failure(HF)is a condition of cardiac dysfunction and fluid overload.Neurohormonal activation via the reninangiotensin-aldosterone system and the sympathetic nervous system are the pathophysiological cornerstones.[1]Furthermore,HF is a disorder widely associated with grave adverse outcomes and poor prognosis.[2]A loop diuretic is the fundamental drug used to prevent multiorgan failure and improve symptoms in these patients.[3]

关 键 词：FUROSEMIDE Heart failure INFUSION INJECTION MORTALITY 

分 类 号：R541.6[医药卫生—心血管疾病]